Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Suhr

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytesW G Bessler, M Cox, A Lex, et al.
Cephalalgia : an International Journal of Headache|April 1, 1999
Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapyB Suhr, S Evers, B Bauer, et al.
Transplantation|March 8, 2012
Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosisSandra Gustafsson, Elisabet Ihse, Michael Y Henein, et al.
Orphanet Journal of Rare Diseases|April 29, 2014
THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare diseaseJonas Wixner, Rajiv Mundayat, Onur N Karayal, et al.
Current Opinion in Neurology|January 7, 2016
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAPYesim Parman, David Adams, Laura Obici, et al.
Journal of Internal Medicine|August 22, 2003
Hereditary transthyretin amyloidosis from a Scandinavian perspectiveO B Suhr, I Hastrup Svendsen, R Andersson, et al.
Journal of Internal Medicine|December 12, 2007
Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?O B Suhr, I Anan, C Backman, et al.
Therapeutic Advances in Gastroenterology|November 18, 2017
The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis: a retrospective observational studyAghil Ibrahim, Per Dahlqvist, Tommy Olsson, et al.
Degenerative Neurological and Neuromuscular Disease|March 21, 2019
New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experienceOle B Suhr, Sandra Gustavsson, Victoria Heldestad, et al.
Annals of Medicine|November 28, 2015
Evolving landscape in the management of transthyretin amyloidosisPhilip N Hawkins, Yukio Ando, Angela Dispenzeri, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytesW G Bessler, M Cox, A Lex, et al.
Cephalalgia : an International Journal of Headache|April 1, 1999
Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapyB Suhr, S Evers, B Bauer, et al.
Transplantation|March 8, 2012
Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosisSandra Gustafsson, Elisabet Ihse, Michael Y Henein, et al.
Orphanet Journal of Rare Diseases|April 29, 2014
THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare diseaseJonas Wixner, Rajiv Mundayat, Onur N Karayal, et al.
Current Opinion in Neurology|January 7, 2016
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAPYesim Parman, David Adams, Laura Obici, et al.
Journal of Internal Medicine|August 22, 2003
Hereditary transthyretin amyloidosis from a Scandinavian perspectiveO B Suhr, I Hastrup Svendsen, R Andersson, et al.
Journal of Internal Medicine|December 12, 2007
Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?O B Suhr, I Anan, C Backman, et al.
Therapeutic Advances in Gastroenterology|November 18, 2017
The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis: a retrospective observational studyAghil Ibrahim, Per Dahlqvist, Tommy Olsson, et al.
Degenerative Neurological and Neuromuscular Disease|March 21, 2019
New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experienceOle B Suhr, Sandra Gustavsson, Victoria Heldestad, et al.
Annals of Medicine|November 28, 2015
Evolving landscape in the management of transthyretin amyloidosisPhilip N Hawkins, Yukio Ando, Angela Dispenzeri, et al.
Pageof 18